Vision problems are a leading source of modifiable health expenditures
- PMID: 24335062
- DOI: 10.1167/iovs.13-12818
Vision problems are a leading source of modifiable health expenditures
Abstract
According to recent studies, visual problems represent one of the top contributors to economic health burden in the United States. This burden is divided nearly equally between direct expenditures for the care and treatment of visual problems, and the indirect costs of outcomes caused by low vision, including productivity losses, the cost of care, and incremental nursing home placements. A large amount of academic research is devoted to visual science, the biology of the visual system, and the medical treatment of visual disorders. Compared to the burden, a disproportionate share of this research is devoted to the study of retinal disorders and glaucoma. This is understandable, as research into the retina and optic nerve has the potential to unlock fundamental insights into the nature of sight and visual cognition. However, population visual health and the functionality that depends upon it also may benefit greatly from additional research into areas of prevention, rehabilitation, and adaptation. In addition, comparative research into the benefits of resource allocation across prevention, treatment, and rehabilitative resources could lead to improvements in population health.
Keywords: cost-effectiveness; economics; resource allocation; review; value of information.
Similar articles
-
The economic burden of major adult visual disorders in the United States.Arch Ophthalmol. 2006 Dec;124(12):1754-60. doi: 10.1001/archopht.124.12.1754. Arch Ophthalmol. 2006. PMID: 17159036
-
Comparison of resource utilization in the treatment of open-angle glaucoma between two cities in Finland: is more better?Acta Ophthalmol. 2013 May;91 Thesis 3:1-47. doi: 10.1111/aos.12141. Acta Ophthalmol. 2013. PMID: 23621767
-
The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.Ophthalmology. 2009 May;116(5):823-32. doi: 10.1016/j.ophtha.2008.12.056. Epub 2009 Mar 14. Ophthalmology. 2009. PMID: 19285730
-
Economic costs of diabetes in the U.S. In 2007.Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017. Diabetes Care. 2008. PMID: 18308683 Review.
-
The cost of visual impairment: purposes, perspectives, and guidance.Invest Ophthalmol Vis Sci. 2010 Apr;51(4):1801-5. doi: 10.1167/iovs.09-4469. Epub 2010 Jan 13. Invest Ophthalmol Vis Sci. 2010. PMID: 20071669 No abstract available.
Cited by
-
Diabetic Eye Screening: Knowledge and Perspectives from Providers and Patients.Curr Diab Rep. 2017 Aug 31;17(10):94. doi: 10.1007/s11892-017-0911-2. Curr Diab Rep. 2017. PMID: 28856510 Free PMC article. Review.
-
Dendrimers for Ocular Drug Delivery.Can J Chem. 2017 Sep;95(9):897-902. doi: 10.1139/cjc-2017-0193. Epub 2017 May 11. Can J Chem. 2017. PMID: 29147035 Free PMC article.
-
Restoring the Extracellular Matrix: A Neuroprotective Role for Collagen Mimetic Peptides in Experimental Glaucoma.Front Pharmacol. 2021 Nov 2;12:764709. doi: 10.3389/fphar.2021.764709. eCollection 2021. Front Pharmacol. 2021. PMID: 34795592 Free PMC article.
-
Commentary: "Mental Distress in Patients with Cerebral Visual Injury Assessed with the German Brief Symptom Inventory".Front Aging Neurosci. 2015 Jun 29;7:122. doi: 10.3389/fnagi.2015.00122. eCollection 2015. Front Aging Neurosci. 2015. PMID: 26175686 Free PMC article. No abstract available.
-
Prevalence of Eye Conditions, Utilization of Eye Health Care Services, and Ophthalmic Medications After Entering Residential Aged Care in Australia.Transl Vis Sci Technol. 2021 Dec 1;10(14):3. doi: 10.1167/tvst.10.14.3. Transl Vis Sci Technol. 2021. PMID: 34854894 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical